Review
The occurrence and management of fluid retention associated with TKI therapy in CML, with a focus on dasatinib
-
* Corresponding author: Allen S Yang allenyan@usc.edu
Journal of Hematology & Oncology 2009, 2:46 doi:10.1186/1756-8722-2-46
No comments have yet been made on this article.